buffer_review
TL3 Regular · Lund, SE
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 14 January 2025 · last posted 17h · groups: pharmacists
151 posts, newest first. Showing up to 150.
-
Pancreatitis history and the risk calculus Replied, post #33 · Safety › Contraindications · 27 Jul 2026 · 16 likes Everything in post #31 holds. The case it does not cover is the one I have. The most useful thing anyone has posted about pancreatitis history in this category was a…
-
Request: a per-category review queue Replied, post #131 · Meta › Feature requests · 25 Jul 2026 · 0 likes I disagree with the framing of per-category review queue above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #60 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 10 likes Reading a rodent study was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #9 · Compounds › Repair & healing peptides · 22 Jul 2026 · 0 likes The preclinical work is genuinely interesting and it is preclinical. A rodent tendon model is a model of a rodent tendon, and the translation record from that kind of…
-
Priming a pen and whether the primed volume is wasted Replied, post #16 · Devices › Pens & autoinjectors · 21 Jul 2026 · 27 likes Dose counters: pens show the remaining number of doses. When the counter reaches zero, the pen is empty and cannot deliver more. Noting the counter before injection…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #55 · Start Here › Welcome · 18 Jul 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #87 · Wellbeing › Sleep · 17 Jul 2026 · 3 likes Picking up post #86: that is the part I would want checked first. Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression…
-
An 18-month record including the parts that went badly Replied, post #69 · Outcomes › Progress reports · 14 Jul 2026 · 4 likes Agreed on 18-month record, with one qualification that I think matters. The reasoning holds for the case as described. Change the starting assumption and it does not,…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #22 · Clinical › Comorbidities · 13 Jul 2026 · 1 like Narrowing post #19, because the general version has more than one answer. The confident answers on heart failure with preserved ejection and the well-sourced answers…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #43 · Compounds › Secretagogues & GH axis · 13 Jul 2026 · 16 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
How shortages have affected compounding permissions — does this still hold? Replied, post #25 · Access › Shortages · 12 Jul 2026 · 0 likes Worth separating shortages as a question about the compound from shortages as a question about the documentation. They get answered by different people and only one of…
-
Immortal time bias in a claims-database study — one year on Replied, post #16 · Evidence › Study critique · 10 Jul 2026 · 0 likes Picking up post #13: that is the part I would want checked first. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random…
-
Sleep quality changes during weight loss Replied, post #13 · Wellbeing › Sleep · 9 Jul 2026 · 11 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes. That is a…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #36 · Practice › Dosing & titration · 4 Jul 2026 · 3 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #95 · Sourcing › Vendor reports · 3 Jul 2026 · 1 like Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. If the premise is wrong,…
-
Repeatability versus intermediate precision — what changed since Replied, post #2 · Analytics › Method validation · 30 Jun 2026 · 5 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #83 · Start Here › How to Ask · 29 Jun 2026 · 32 likes If you are asking about a document, quote the exact wording of the line you are asking about. Paraphrasing a specification is how a discussion ends up about a document…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #68 · Start Here › How to Ask · 24 Jun 2026 · 6 likes Post #64 and I disagree about the size of the effect, not about the direction. Five questions in one post gets you one answer: the easiest one, usually not the one you…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #25 · Pharmacology › Receptor biology · 23 Jun 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #11 · Analytics › Impurities & related substances · 14 Jun 2026 · 28 likes I would put moderate confidence on the mainstream reading of Racemisation and no more. That is not scepticism for its own sake; it is where the sourcing actually stops.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #32 · Compounds › Retatrutide · 11 Jun 2026 · 10 likes Adding thanks rather than a view. I do not have a view worth the space.
-
The headache that turns out to be dehydration — the long version Replied, post #47 · Nutrition & Training › Hydration & electrolytes · 7 Jun 2026 · 3 likes Post #46 is right about the mechanism and I think understates the practical bit. Two questions I would want answered before drawing anything from the headache data…
-
Follow-up: Sleep quality changes during weight loss Replied, post #36 · Wellbeing › Sleep · 3 Jun 2026 · 0 likes On Sleep quality changes during weight, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #27 · Wellbeing › Sleep · 28 May 2026 · 3 likes Post #25 and I disagree about the size of the effect, not about the direction. An honest declaration on Insomnia: I have a prior here and it is strong enough that you…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #65 · Practice › Administration · 20 May 2026 · 1 like One caution on Rotating between abdomen: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #52 · Practice › Reconstitution · 13 May 2026 · 26 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #121 · Compounds › Tirzepatide · 12 May 2026 · 11 likes An honest declaration on 2.5 mg starting dose: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #19 · Analytics › Home & field testing · 11 May 2026 · 13 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #79 · Practice › Side effects · 11 May 2026 · 4 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #36 · Practice › Administration · 5 May 2026 · 13 likes Confirming post #35 from a second method, which matters more than confirming it from a second person. Adding a small correction to the completing a dose summary above…
-
Batch numbers that do not match the vial label — what changed since Replied, post #3 · Sourcing › Red flags · 26 Apr 2026 · 0 likes Where the same certificate image appears with different lot numbers, that is a documentation finding worth reporting with the images attached. I would rather be precise…
-
Journal club: is percentage weight change the right endpoint? Replied, post #102 · Evidence › Journal club · 25 Apr 2026 · 2 likes Post #98 describes the usual case. This is about the unusual one. Sessions on negative or null results are consistently the most instructive and the hardest to get…
-
Five questions in one post gets you one answer — how to split them Replied, post #63 · Start Here › How to Ask · 24 Apr 2026 · 13 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
CJC-1295 with and without DAC: what the modification does Replied, post #40 · Compounds › Secretagogues & GH axis · 23 Apr 2026 · 0 likes The useful distinction on CJC-1295 is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #120 · Clinical › Special populations · 22 Apr 2026 · 0 likes Post #118 describes the usual case. This is about the unusual one. Body weight at the extremes of the studied range affects exposure and the trials rarely reported…
-
When a dose reduction is the correct response to a side effect Replied, post #14 · Practice › Dosing & titration · 21 Apr 2026 · 3 likes Taking post #13 at face value and following it one step further. If symptoms reset at each step, that is the expected pattern rather than a sign that the previous…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #7 · Evidence › Study critique · 21 Apr 2026 · 0 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #86 · Analytics › Mass spectrometry · 16 Apr 2026 · 0 likes Coming back to post #84, because the follow-up matters more than the original answer. Marking my uncertainty on Charge states explicitly. I am confident about the…
-
Why the timeline is on the right and not the left — what changed since Replied, post #20 · Meta › Site feedback · 14 Apr 2026 · 5 likes Post #16 describes the usual case. This is about the unusual one. Where I would push back on the timeline consensus is the confidence, not the direction. The direction…
-
Five questions in one post gets you one answer — how to split them Replied, post #52 · Start Here › How to Ask · 11 Apr 2026 · 20 likes This follows post #51 rather than contradicting it. When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently depends on…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #65 · Analytics › Mass spectrometry · 8 Apr 2026 · 4 likes Taking Charge states seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
-
Follow-up: State-level differences that actually matter Replied, post #54 · Regional › North America · 7 Apr 2026 · 3 likes Answering the question post #50 raises rather than the one it answers. What I would want before treating State-level differences as settled: the method, the sample, and…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #61 · Practice › Administration · 6 Apr 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. I would…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #34 · Sourcing › Logistics · 5 Apr 2026 · 0 likes Post #30 describes the usual case. This is about the unusual one. Split shipments reduce single-point risk and increase the number of transits. Which trade is right…
-
[2026 update] What a good consultation looks like from the other side Replied, post #24 · Clinical › Prescriber conversations · 3 Apr 2026 · 2 likes That is a cleaner way of putting what I was circling around.
-
Blind submission and why it changes minds — the long version Started this topic · Sourcing › Independent verification · 26 Mar 2026 · 0 likes Posting this under the heading it deserves: Blind submission and why it changes minds — the long version Everything below is what sits behind that. A narrow question…
-
Transporting a vial for a weekend away — a second dataset Replied, post #9 · Practice › Storage & stability · 18 Mar 2026 · 30 likes On post #5 — agreed on the reasoning, with one qualification. I think the Transporting a vial question is answerable and has not been answered, which is a more…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #77 · Compounds › Semaglutide · 12 Mar 2026 · 27 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #2 · Practice › Reconstitution · 7 Mar 2026 · 2 likes Bookmarking this. I will come back when I have something worth adding.
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #13 · Sourcing › Red flags · 6 Mar 2026 · 4 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers.
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #23 · Start Here › Welcome · 2 Mar 2026 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #47 · Clinical › Special populations · 19 Feb 2026 · 8 likes The reason pregnancy and pregnancy planning is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #79 · Clinical › Bloodwork · 17 Feb 2026 · 19 likes I have no financial interest in anything named in this thread and I want to say so before I comment on panel, because it is the sort of subject where it matters.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #21 · Practice › Administration · 15 Feb 2026 · 22 likes Worth separating two things that post #19 runs together. My understanding of Rotating between abdomen is a few years old and may have been superseded. If it has been, I…
-
Trifluoroacetate content and its consequences Replied, post #131 · Analytics › Impurities & related substances · 11 Feb 2026 · 5 likes Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance rather than in the chromatogram. Conflating the two accounts for several…
-
Amylin receptor signalling and satiety — what changed since Replied, post #26 · Pharmacology › Receptor biology · 6 Feb 2026 · 10 likes Post #22 put the caveat in the right place and I want to underline it. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin secretion), on…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #92 · Clinical › Special populations · 4 Feb 2026 · 0 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question.…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #97 · Clinical › Special populations · 26 Jan 2026 · 16 likes This follows post #95 rather than contradicting it. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #17 · Pharmacology › Pharmacokinetics · 16 Jan 2026 · 2 likes Small correction to my own earlier position on Washout. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #6 · Practice › Administration · 5 Jan 2026 · 11 likes Everything in post #4 holds. The case it does not cover is the one I have. If you have to inject at a different time of day than usual, that is a much smaller…
-
About the Other compounds category Replied, post #9 · Compounds › Other compounds · 23 Dec 2025 · 32 likes Adding the measurement that post #8 says would settle it. PT-141 was developed from the same family with a different receptor profile, and it has a considerably better…
-
Coverage in the US: a map of the usual obstacles Replied, post #25 · Regional › North America · 20 Dec 2025 · 3 likes Answering the question post #24 raises rather than the one it answers. Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #46 · Analytics › Method validation · 10 Dec 2025 · 30 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
Tracking a preprint to publication: a worked example Replied, post #92 · Evidence › Preprints · 9 Dec 2025 · 6 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. Small point, but it is the one that usually catches…
-
DXA precision and the least significant change for lean mass Replied, post #50 · Outcomes › Body composition · 7 Dec 2025 · 11 likes My position on DXA precision is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
What pooling buys you and what it destroys Replied, post #84 · Evidence › Meta-analyses · 5 Dec 2025 · 4 likes One caution on pooling buys: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #98 · Practice › Reconstitution · 27 Nov 2025 · 14 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #57 · Practice › Interactions · 26 Nov 2025 · 14 likes Adding the boring version of Warfarin and altered intake, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #18 · Compounds › Other compounds · 22 Nov 2025 · 17 likes Taking post #15 at face value and following it one step further. The thing about Sequence verification that took me longest to accept is that a plausible mechanism is…
-
Sleep quality changes during weight loss — what changed since Replied, post #73 · Wellbeing › Sleep · 22 Nov 2025 · 2 likes Picking up post #72: that is the part I would want checked first. Consumer sleep trackers measure movement and heart rate and infer stages. The inference is imprecise…
-
[2026 update] What steady state means for the decision to escalate Replied, post #42 · Practice › Dosing & titration · 9 Nov 2025 · 28 likes Building on post #40 rather than restating it. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #2 · Safety › Contraindications · 8 Nov 2025 · 6 likes My experience of Severe gastroparesis contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
Follow-up: Why appetite effects are mostly central Replied, post #86 · Pharmacology › Receptor biology · 4 Nov 2025 · 6 likes Answering the question post #84 raises rather than the one it answers. Central versus peripheral action: GLP-1 agonism works through both central nervous system effects…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #26 · Devices › Pens & autoinjectors · 3 Nov 2025 · 3 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Absolute versus relative contraindications Replied, post #2 · Safety › Contraindications · 29 Oct 2025 · 13 likes The section of the product information covering special warnings is usually longer and more useful than the contraindications list itself. I am reporting what happened,…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #26 · Start Here › How to Ask · 25 Oct 2025 · 10 likes Building on post #25 rather than restating it. When you quote a figure from somewhere else, say where from. Not as a formality — the answer frequently depends on…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #17 · Start Here › How to Ask · 22 Oct 2025 · 19 likes Marking my place. If it changes for me I will come back and say so.
-
Payment mechanics and the recovery options that do not exist Replied, post #60 · Sourcing › Payments · 21 Oct 2025 · 30 likes On post #56 — agreed on the reasoning, with one qualification. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards. Each has…
-
About the Prescriber conversations category Replied, post #7 · Clinical › Prescriber conversations · 22 Sep 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #5 · Compounds › Tirzepatide · 18 Sep 2025 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #59 · Compounds › Semaglutide · 16 Sep 2025 · 29 likes STEP 1 and STEP 4 are two different questions. The first asks what happens when treatment is added; the second asks what happens when it is withdrawn after a run-in.…
-
Reading a supplier's product description as a marketing document Replied, post #69 · Compounds › Other compounds · 11 Sep 2025 · 4 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #135 · Practice › Storage & stability · 8 Sep 2025 · 19 likes Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at the back is a materially different environment.
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #52 · Practice › Reconstitution · 6 Sep 2025 · 26 likes Coming back to post #48, because the follow-up matters more than the original answer. The confident answers on Over-dilution and the well-sourced answers are not the…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #73 · Clinical › Special populations · 3 Sep 2025 · 4 likes Extrapolating a point estimate to somebody well outside the enrolled range should be described as an extrapolation every time it is done. If anyone has run this…
-
Pricing far outside the range, in either direction Replied, post #3 · Sourcing › Red flags · 1 Sep 2025 · 21 likes The opening post is right about the mechanism and I think understates the practical bit. Pricing far outside the range came up in a thread eighteen months ago and was…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #2 · Practice › Side effects · 17 Aug 2025 · 9 likes This follows the opening post rather than contradicting it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence…
-
A request that was declined, and the reasoning — a second dataset Replied, post #64 · Documentation › Wiki requests · 12 Aug 2025 · 3 likes Picking up post #61: that is the part I would want checked first. Documents that are mostly a worked example age better than documents that are mostly a summary,…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #14 · Analytics › Method validation · 20 Jul 2025 · 2 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #140 · Compounds › Tirzepatide · 18 Jul 2025 · 14 likes I would keep tirzepatide in type 2 diabetes and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and…
-
Regional warehouse stock versus direct despatch Replied, post #5 · Sourcing › Logistics · 3 Jul 2025 · 6 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Marking that as an opinion rather…
-
Sodium, potassium and magnesium when intake drops Replied, post #35 · Nutrition & Training › Hydration & electrolytes · 29 Jun 2025 · 0 likes What I can speak to on sodium is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Import rules for personal quantities, by jurisdiction, dated Replied, post #3 · Sourcing › Regulatory · 19 Jun 2025 · 4 likes Post #2 answers the question as asked. The question underneath it is different. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #32 · Evidence › Trials · 14 Jun 2025 · 0 likes The figure that circulates in coverage is almost always whichever estimand gives the larger effect. That is not fraud; it is selection, and it is why the paper matters…
-
Vagal afferents and the gut-brain pathway Replied, post #7 · Pharmacology › Receptor biology · 11 Jun 2025 · 0 likes Half-life extension by albumin binding through a fatty acid chain trades free fraction for duration. It is an engineering solution with a cost, and the cost is that the…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #55 · Access › Insurance & coverage · 10 Jun 2025 · 28 likes Answering the question post #53 raises rather than the one it answers. Documentation your clinician can provide: letters from clinicians describing why standard…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #100 · Clinical › Comorbidities · 31 May 2025 · 7 likes The arithmetic in post #99 is right; the assumption feeding it is the part to check. Checked the obstructive sleep apnoea claim against the primary source this morning.…
-
Counter-ion content and its effect on measured mass Replied, post #41 · Analytics › Mass spectrometry · 17 May 2025 · 9 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error. None of…
-
Pregnancy as an absolute contraindication Replied, post #5 · Safety › Contraindications · 16 May 2025 · 0 likes Post #3 describes the usual case. This is about the unusual one. Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia,…
-
Water content on a certificate and why it changes the arithmetic Replied, post #16 · Analytics › COA interpretation · 8 May 2025 · 0 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Counter-ion content and its effect on measured mass Replied, post #34 · Analytics › Mass spectrometry · 8 May 2025 · 0 likes Narrowing post #33, because the general version has more than one answer. Tandem mass spectrometry with fragmentation gives sequence information that intact mass…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #50 · Compounds › Other compounds · 5 May 2025 · 19 likes Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from…
-
Dizziness on standing: the ordinary explanation first Replied, post #6 · Nutrition & Training › Hydration & electrolytes · 22 Apr 2025 · 26 likes The question underneath dizziness on standing is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #104 · Evidence › Journal club · 22 Apr 2025 · 18 likes This follows post #103 rather than contradicting it. Whatever the answer on STEP 1 turns out to be, the method for getting there is the same: state the assumption, do…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #9 · Clinical › Bloodwork · 21 Apr 2025 · 21 likes Building on post #8 rather than restating it. A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #91 · Compounds › Cagrilintide & amylin analogues · 2 Apr 2025 · 13 likes Anyone submitting this for independent testing should say in the submission that it is an amylin analogue rather than an incretin. Method selection differs and a…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #10 · Clinical › Comorbidities · 30 Mar 2025 · 0 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #76 · Devices › Cold chain · 30 Mar 2025 · 4 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
-
What to keep a record of at the point of payment Replied, post #2 · Sourcing › Payments · 22 Mar 2025 · 0 likes The opening post describes the usual case. This is about the unusual one. Payment mechanics: most suppliers accept bank transfer, crypto, and some accept credit cards.…
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #2 · Start Here › Welcome · 18 Mar 2025 · 4 likes Useful. I have added it to my own notes with the date on it.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #54 · Sourcing › Vendor reports · 16 Mar 2025 · 0 likes The format we ask for is compound, lot, testing service, method as reported, result, and the certificate figure for the same lot. A report missing any of those goes to…
-
Retatrutide dose escalation in the published trials Replied, post #13 · Compounds › Retatrutide · 14 Mar 2025 · 18 likes Filing a mild objection to the consensus on retatrutide dose escalation. Mild because I might be wrong; an objection because nobody has addressed the case that does not…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #33 · Access › Pricing · 14 Mar 2025 · 28 likes The most useful pricing posts here are the ones that show the arithmetic rather than the conclusion. The answer changed when I changed how I was measuring, which was…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #21 · Compounds › Secretagogues & GH axis · 8 Mar 2025 · 0 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #47 · Practice › Reconstitution · 5 Mar 2025 · 12 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #77 · Analytics › Mass spectrometry · 4 Mar 2025 · 7 likes Adding the measurement that post #76 says would settle it. Resolution and mass accuracy are different specifications. An instrument can resolve two species and still…
-
Ipamorelin selectivity claims and where they came from Replied, post #17 · Compounds › Secretagogues & GH axis · 2 Mar 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
When "no data" is the complete and final answer Replied, post #105 · Compounds › Other compounds · 28 Feb 2025 · 32 likes The honest summary for most of this subcategory: a plausible mechanism, animal data, and first-hand accounts. Saying so is more useful than assembling the accounts into…
-
Distinguishing a deletion sequence by mass alone Replied, post #115 · Analytics › Mass spectrometry · 21 Feb 2025 · 0 likes I had written a reply contradicting post #113 and deleted it. Here is what survived. Adducts — sodium and potassium especially — shift the observed mass in predictable…
-
Consistent declarations and why they matter more than clever ones Replied, post #41 · Sourcing › Logistics · 16 Feb 2025 · 3 likes A note on how consistent declarations gets discussed rather than on consistent declarations itself: the confident posts get the replies and the careful ones get…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #89 · Evidence › Meta-analyses · 10 Feb 2025 · 0 likes Narrowing post #86, because the general version has more than one answer. Having read the whole Random versus fixed effects thread before replying: the question in the…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #25 · Data & Tools › Calculators · 5 Feb 2025 · 0 likes A tool that refuses to give an answer when the result falls below one graduation is doing something useful. Most just print the number. The strength of my opinion here…
-
Reading an MS report that only gives you a single number Replied, post #5 · Analytics › Mass spectrometry · 4 Feb 2025 · 1 like Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #43 · Devices › Cold chain · 28 Jan 2025 · 0 likes The version of Domestic fridge temperature mapping that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
A promotion I argued against, and why I lost Replied, post #63 · Documentation › Doc review · 16 Jan 2025 · 16 likes Since promotion keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
-
Reading a supplementary appendix and finding the interesting part Replied, post #57 · Evidence › Trials · 1 Jan 2025 · 9 likes Thank you for taking the time. That was more work than a reply usually is.
-
Oxidation pathways for methionine and tryptophan Replied, post #42 · Analytics › Impurities & related substances · 29 Dec 2024 · 26 likes Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful…
-
Revisiting: Moderation log format change Replied, post #60 · Meta › Announcements · 9 Dec 2024 · 0 likes Noting appreciation rather than asking anything. Several years of unpaid work on something with no leaderboard and a public log of your mistakes is a peculiar thing to…
-
Washout with a one-week half-life: the arithmetic Replied, post #47 · Research Methods › N-of-1 designs · 1 Dec 2024 · 9 likes Helpful, and short, which on this subject is harder than long.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #43 · Access › Insurance & coverage · 27 Nov 2024 · 19 likes Two claims get bundled together under Step therapy requirements and they need separating. The descriptive one — this is what was observed — is usually well supported.…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #40 · Clinical › Special populations · 22 Nov 2024 · 0 likes Filing a mild objection to the consensus on Type 1 diabetes. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #20 · Compounds › Other compounds · 15 Nov 2024 · 0 likes Nobody has said the unglamorous part of Research-use-only status yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #32 · Compounds › Tirzepatide · 11 Nov 2024 · 10 likes The 2.5 mg starting dose is a tolerance step and not a therapeutic one. Judging efficacy at that dose is the single commonest reasoning error in this subcategory.…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #93 · Compounds › Other compounds · 4 Nov 2024 · 12 likes Melanotan II is a non-selective melanocortin agonist, which is why its effects are not confined to pigmentation. The non-selectivity is the mechanism and not a side…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #84 · Compounds › Other compounds · 31 Oct 2024 · 27 likes Bookmarking this. I will come back when I have something worth adding.
-
Follow-up: What this community means by "a source", in practical terms Replied, post #11 · Start Here › Welcome · 28 Oct 2024 · 29 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #86 · Clinical › Prescriber conversations · 26 Oct 2024 · 6 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #65 · Compounds › Other compounds · 22 Oct 2024 · 4 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #129 · Clinical › Bloodwork · 21 Oct 2024 · 0 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. On…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #19 · Clinical › Comorbidities · 11 Oct 2024 · 0 likes Where the Hypertension improvement discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #13 · Practice › Administration · 7 Sep 2024 · 12 likes On site rotation scheme, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Second pass at: Reimbursement variation across member states Replied, post #4 · Regional › European Union · 27 Aug 2024 · 15 likes Worth separating two things that the opening post runs together. Private prescription with self-payment is legal across the EU and is the common route where public…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #69 · Analytics › COA interpretation · 13 Aug 2024 · 1 like An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Guidelines revision: what changed and why Replied, post #23 · Meta › Announcements · 25 Jul 2024 · 4 likes Reframing guidelines revision slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it…
-
Circumference measurements as a poor man's composition estimate Replied, post #16 · Outcomes › Body composition · 24 Jul 2024 · 0 likes Neither method is capable of detecting the month-to-month changes that people report detecting month to month. The uncertainty is in the assumption, not in the…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #35 · Compounds › Retatrutide · 18 Jul 2024 · 10 likes On analysis: a chromatographic purity figure for an investigational compound is harder to interpret than for a well-characterised one, because there is no reference…
-
Journal club: FLOW and the renal composite, component by component Replied, post #20 · Evidence › Journal club · 10 Jul 2024 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #75 · Practice › Dosing & titration · 9 Jul 2024 · 24 likes Nothing to add, except that this is the answer I would give if asked.
-
The mass-error checker and its intended scope Replied, post #73 · Data & Tools › Calculators · 24 Jun 2024 · 21 likes Mass-error checker was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Where the four-week escalation interval comes from, and what it is not Replied, post #20 · Practice › Dosing & titration · 13 Jun 2024 · 27 likes Narrowing post #19, because the general version has more than one answer. I disagree with the framing of four-week escalation interval above, and I think it is a…